Agallou Maria, Margaroni Maritsa, Tsanaktsidou Evgenia, Badounas Fotis, Kammona Olga, Kiparissides Costas, Karagouni Evdokia
Immunology of Infection Laboratory, Hellenic Pasteur Institute, Athens 125 21, Greece.
Chemical Process & Energy Resources Institute, Centre for Research and Technology Hellas, P.O. Box 60361, Thessaloniki 57 001, Greece.
J Control Release. 2023 Apr;356:386-401. doi: 10.1016/j.jconrel.2023.03.006. Epub 2023 Mar 11.
Subunit proteins provide a safe source of antigens for vaccine development especially for intracellular infections which require the induction of strong cellular immune responses. However, those antigens are often limited by their low immunogenicity. In order to achieve effective immune responses, they should be encapsulated into a stable antigen delivery system combined with an appropriate adjuvant. As such cationic liposomes provide an efficient platform for antigen delivery. In the present study, we describe a liposomal vaccine platform for co-delivery of antigens and adjuvants able to elicit strong antigen-specific adaptive immune responses. Liposomes are composed of the cationic lipid dimethyl dioctadecylammonium bromide (DDAB), cholesterol (CHOL) and oleic acid (OA). Physicochemical characterization of the formulations showed that their size was in the range of ∼250 nm with a positive zeta potential which was affected in some cases by the enviromental pH facilitating endosomal escape of potential vaccine cargo. In vitro, liposomes were effectively taken up by bone marrow dendritic cells (BMDCs) and when encapsulated IMQ they promoted BMDCs maturation and activation. Upon in vivo intramuscular administration, liposomes' active drainage to lymph nodes was mediated by DCs, B cells and macrophages. Thus, mice immunization with liposomes having encapsulated LiChimera, a previously characterized anti-leishmanial antigen, and IMQ elicited infiltration of CD11b DCs populations in draining LNs followed by increased antigen-specific IgG, IgG2a and IgG1 levels production as well as indcution of antigen-specific CD4 and CD8 T cells. Collectively, the present work provides a proof-of-concept that cationic liposomes composed of DDAB, CHOL and OA adjuvanted with IMQ provide an efficient delivery platform for protein antigens able to induce strong adaptive immune responses via DCs targeting and induction of maturation.
亚基蛋白为疫苗开发提供了安全的抗原来源,尤其适用于需要诱导强烈细胞免疫反应的细胞内感染。然而,这些抗原往往因其低免疫原性而受到限制。为了实现有效的免疫反应,应将它们封装到与合适佐剂结合的稳定抗原递送系统中。阳离子脂质体为此提供了一个有效的抗原递送平台。在本研究中,我们描述了一种用于共同递送抗原和佐剂的脂质体疫苗平台,该平台能够引发强烈的抗原特异性适应性免疫反应。脂质体由阳离子脂质二甲基二十八烷基溴化铵(DDAB)、胆固醇(CHOL)和油酸(OA)组成。制剂的物理化学特性表明,其大小在约250nm范围内,具有正的ζ电位,在某些情况下会受到环境pH值的影响,这有利于潜在疫苗货物从内体逃逸。在体外,脂质体被骨髓树突状细胞(BMDC)有效摄取,当封装咪喹莫特(IMQ)时,它们促进BMDC的成熟和激活。在体内肌肉注射后,脂质体向淋巴结的主动引流由树突状细胞、B细胞和巨噬细胞介导。因此,用封装了LiChimera(一种先前已表征的抗利什曼原虫抗原)和IMQ的脂质体免疫小鼠,可引发引流淋巴结中CD11b树突状细胞群体的浸润,随后抗原特异性IgG、IgG2a和IgG1水平升高,以及抗原特异性CD4和CD8 T细胞的诱导。总的来说,本研究提供了一个概念验证,即由DDAB、CHOL和OA组成并佐以IMQ的阳离子脂质体为蛋白质抗原提供了一个有效的递送平台,能够通过树突状细胞靶向和诱导成熟来诱导强烈的适应性免疫反应。